Insider Trading Activity For CytomX Therapeutics Inc (NASDAQ:CTMX)
Rachel Humphrey , Insider of CytomX Therapeutics Inc (NASDAQ:CTMX) reportedly Sold 23,840 shares of the company’s stock at an average price of 30 for a total transaction amount of $715,200.00 SEC Form
Insider Trading History For CytomX Therapeutics Inc (NASDAQ:CTMX)
Analyst Ratings History For CytomX Therapeutics Inc (NASDAQ:CTMX)
- On 3/20/2017 Instinet Boost Price Target of rating Sell with a price target of $21.00 to $32.00
- On 5/8/2017 HC Wainwright Reiterated Rating Buy
- On 8/8/2017 Cann Reiterated Rating Hold
- On 8/25/2017 Jefferies Group Set Price Target of rating Buy with a price target of $25.00
- On 10/4/2017 Wedbush Set Price Target of rating Buy with a price target of $26.00 to $37.00
- On 10/4/2017 Nomura Boost Price Target of rating Buy with a price target of $44.00
- On 10/4/2017 Bank of America Boost Price Target of rating Buy with a price target of $30.00 to $34.00
Recent Trading Activity for CytomX Therapeutics Inc (NASDAQ:CTMX)
Shares of CytomX Therapeutics Inc closed the previous trading session at 30.87 up +1.11 3.73% with 29.68000030517578 shares trading hands.